Ascension St. Vincent’s is using new technology to treat patients with atrial fibrillation (A-fib).

Scientists are using ex-vivo, or beating donated human hearts, to test a new way of pinpointing the source of AFib.

Atrial Fibrillation, or AFib, is an irregular heartbeat that can cause poor blood flow. Atrial Fibrillation, or AFib, is an irregular heartbeat that can cause poor blood flow. Patients received the standard medication, or a cryo balloon ablation. After a year, 75% of the patients who received an ablation were still free from AFib. AdIn comparison, only 45% of the patients who received medication were still AFib-free.